[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100115485":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":26,"responsibleParty":42,"collaborators":11,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":11,"maxAge":11,"enrollmentInfo":55,"targetDuration":11,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":29,"whyStopped":11,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"The Chaim Sheba Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"1","EXPERIMENTAL",null,[13],"Drug: methylphenidate, fluoxetin, risperidone",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DRUG","methylphenidate, fluoxetin, risperidone","first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Doron Gothelf, MD","CONTACT","972-03-5302663","gothelf@post.tau.ac.il",[27],{"facility":28,"status":29,"city":30,"state":11,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Schneider Children's Mediac Center of Israel","RECRUITING","Petah Tikva","49202","Israel","IL",{"type":35,"coordinates":36},"Point",[37,38],34.88747,32.08707,{"lat":38,"lon":37},[41],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":11},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Prof. Doron Gothelf","Principal Investigator","100115485","phase-4-the-psychiatric-and-cognitive-phenotypes-in-velocardiofacial-syndrome-100115485",false,"NCT00768820","The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome","The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors","VCFS","Inclusion Criteria:\n\n* chromosomal deletion proven by FISH examination\n\nExclusion Criteria:","ALL",{"count":56,"type":57},400,"ESTIMATED","INTERVENTIONAL",[60],"PHASE4","The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors",[63,64,65],"Velocardiofacial Syndrome","Williams Syndrome","Fragile X Syndrome",[67,68,69,70,71],"Velocardiofacial syndrome","Williams syndrome","fragile X syndrome","cognitive phenotype","psychiatric phenotype","2026-03-17",{"date":74,"type":75},"2026-03-18","ACTUAL",{"date":77,"type":11},"2001-05",{"date":79,"type":57},"2027-08",{"name":5,"class":6},1]